Citigroup Downgrades Insulet to Neutral, Lowers Price Target to $230

Benzinga Newsdesk www.benzinga.com Negative 88.7%

Neg 88.7% Neu 0% Pos 0%

Citigroup analyst Joanne Wuensch downgrades Insulet (NASDAQ:PODD) from Buy to Neutral and lowers the price target from $338 to $230.